dc.contributor.author | Reglero, Clara | |
dc.contributor.author | Lafarga Berciano, Vanesa | |
dc.contributor.author | Rivas, Veronica | |
dc.contributor.author | Albitre, Ángela | |
dc.contributor.author | Ramos, Paula | |
dc.contributor.author | Berciano, Susana | |
dc.contributor.author | Tapia Martínez, Olga | |
dc.contributor.author | Martínez Chantar, María L. | |
dc.contributor.author | Mayor, Federico | |
dc.contributor.author | Penela, Petronila | |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2020-10-01T14:27:25Z | |
dc.date.available | 2020-10-01T14:27:25Z | |
dc.date.issued | 2020-05 | |
dc.identifier.issn | 2072-6694 | |
dc.identifier.other | SAF2017-84125-R | es_ES |
dc.identifier.other | SAF2017-87301-R | es_ES |
dc.identifier.uri | http://hdl.handle.net/10902/19263 | |
dc.description.abstract | Adaptation to hypoxia is a common feature in solid tumors orchestrated by oxygen-dependent and independent upregulation of the hypoxia-inducible factor-1? (HIF-1?). We unveiled that G protein-coupled receptor kinase (GRK2), known to be overexpressed in certain tumors, fosters this hypoxic pathway via phosphorylation of the mRNA-binding protein HuR, a central HIF-1? modulator. GRK2-mediated HuR phosphorylation increases the total levels and cytoplasmic shuttling of HuR in response to hypoxia, and GRK2-phosphodefective HuR mutants show defective cytosolic accumulation and lower binding to HIF-1? mRNA in hypoxic Hela cells. Interestingly, enhanced GRK2 and HuR expression correlate in luminal breast cancer patients. GRK2 also promotes the HuR/HIF-1? axis and VEGF-C accumulation in normoxic MCF7 breast luminal cancer cells and is required for the induction of HuR/HIF1-? in response to adrenergic stress. Our results point to a relevant role of the GRK2/HuR/HIF-1? module in the adaptation of malignant cells to tumor microenvironment-related stresses. | es_ES |
dc.description.sponsorship | Acknowledgments: Our laboratories are supported by Instituto de Salud Carlos III, Spain, with FEDER cofinancing (grants PI14-00435 and PI17-00576 to PP); by Ministerio de Economía; Industria y Competitividad (MINECO) of Spain (grant SAF2017-84125-R to F.M. and SAF2017-87301-R (to M.L.M-C); by CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M, co-funded with European Regional Development Fund-FEDER contribution); by Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE and Fundación Ramón Areces to F.M.); and by Asociación Española contra el Cáncer, Canceres raros, La Caixa Foundation, and Ayudas Fundación BBVA (to M.L.M-C).We also acknowledge institutional support to the CBMSO from Fundación Ramón Areces and MINECO (SEV-2016-0644) for the Severo Ochoa Excellence Accreditation. | es_ES |
dc.format.extent | 21 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.rights | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license. | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | Cancers (Basel)
. 2020 May 13;12(5):1216 | es_ES |
dc.subject.other | Hypoxia | es_ES |
dc.subject.other | [beta]-Adrenergic Signaling | es_ES |
dc.subject.other | Breast Cancer | es_ES |
dc.subject.other | mRNA Regulation | es_ES |
dc.subject.other | Nucleocytoplasmic Shuttling | es_ES |
dc.subject.other | GRK2 | es_ES |
dc.subject.other | HuR | es_ES |
dc.subject.other | HIF1[alfa] | es_ES |
dc.subject.other | VEGF | es_ES |
dc.title | GRK2-Dependent HuR Phosphorylation Regulates HIF1? Activation under Hypoxia or Adrenergic Stress | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | http://dx.doi.org/10.3390/cancers12051216 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2017-84125-R/ES/GRK2 COMO NODO DE SEÑALIZACION INTEGRADOR EN SITUACIONES FISIOPATOLOGICAS/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2017-87301-R/ES/EL PAPEL DE LA NEDILACION EN LA ESTEATOHEPATITIS NO ALCOHOLICA Y SU PROGRESION A CIRROSIS Y CANCER HEPATICO/ | es_ES |
dc.identifier.DOI | 10.3390/cancers12051216 | |
dc.type.version | publishedVersion | es_ES |